Cardiac
Markers
Myocardial injury biomarkers are released into the bloodstream when cardiac muscle cells are damaged. Their appearance and concentration patterns vary according to the extent and timing of the injury, providing important diagnostic and prognostic information. The combined assessment of these biomarkers supports the evaluation of acute myocardial injury, facilitating both early detection and retrospective clinical analysis. KSB cardiac marker assays provide valuable clinical diagnostic information to support timely decision-making in patient care.
VeriGoldTM
Gold-Conjugated Immunoassay
VeriLumenTM Fluorescence Immunoassay
Cardiac injury is a major pathological condition encountered in clinical practice and may result from myocardial ischemia or direct damage to heart tissue. It is commonly associated with cardiovascular disorders such as acute myocardial infarction, angina pectoris, myocarditis, heart failure, and other forms of cardiac dysfunction. These conditions can significantly impair cardiac performance and may rapidly progress if not properly diagnosed and managed, making early identification of myocardial damage clinically essential.
Clinically, cardiac injury may present with symptoms including chest pain, shortness of breath, fatigue, palpitations, and reduced exercise capacity, all reflecting impaired cardiac function. In many cases, these symptoms are accompanied by biochemical changes in the blood, particularly elevated cardiac biomarker levels that indicate myocardial stress or injury. Monitoring these changes is important for early detection, risk stratification, and guiding timely therapeutic intervention in acute and chronic cardiovascular conditions.
Cardiac markers can be measured in biological samples such as whole blood, serum, and plasma, depending on the specific analyte and intended clinical use. Their detection is commonly performed using immunological and biochemical methods designed to provide high sensitivity, specificity, and reproducibility. Among these, immunoassay-based technologies are widely used in clinical diagnostics due to their reliability, rapid performance, and compatibility with standardized laboratory and point-of-care workflows.
Explore
Your
Options
Shenzhen Kang Sheng Bao
Biotechnology Co., Ltd.
Second Floor, Block 3, Anda
Electronic Industrial Park,
Fuhai, Bao’an District,
518103 Shenzhen,
Guangdong Province, PRC
+86 0755 27417763
info@ksbbiotech.com
© 2026 Shenzhen Kang Sheng Bao Bio-Technology Co., Ltd. All Rights Reserved